Ativan (Page 5 of 5)

PRINCIPAL DISPLAY PANEL — 2.0 mg Bottle Label

NDC 0187-0065-01

Rx only

Ativan®
(lorazepam) Tablets

CIV
SEALED
FOR YOUR
PROTECTION

2 mg

PHARMACIST: Dispense the accompanying Medication Guide to each patient.

100 Tablets

BAUSCH Health

2mglabel
(click image for full-size original)

Package/Label Display Panel

NDC 0187-0064-01

Rx only

Ativan®
(lorazepam) Tablets

CIV
SEALED
FOR YOUR PROTECTION

1 mg

PHARMACIST: Dispense the accompanying Medication Guide to each patient.

100 Tablets

BAUSCH Health

1mg label
(click image for full-size original)

Package/Label Display Panel -.5 mg Bottle Label

NDC 0187-0063-01

Rx only

Ativan®
(lorazepam) Tablets

CIV
SEALED
FOR YOUR PROTECTION

0.5 mg

PHARMACIST: Dispense the accompanying Medication Guide to each patient.

100 Tablets

BAUSCH Health

0.5mg-label
(click image for full-size original)

ATIVAN lorazepam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0187-0063
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
lorazepam (lorazepam) lorazepam 0.5 mg
Inactive Ingredients
Ingredient Name Strength
lactose monohydrate
MAGNESIUM STEARATE
POLACRILIN POTASSIUM
MICROCRYSTALLINE CELLULOSE
Product Characteristics
Color WHITE Score no score
Shape PENTAGON (5 sided) (SHIELD SHAPE) Size 5mm
Flavor Imprint Code A;BPI;63
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0187-0063-01 100 TABLET in 1 BOTTLE None
2 NDC:0187-0063-50 500 TABLET in 1 BOTTLE None
3 NDC:0187-0063-10 1000 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017794 05/01/2013
ATIVAN lorazepam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0187-0064
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
lorazepam (lorazepam) lorazepam 1 mg
Inactive Ingredients
Ingredient Name Strength
lactose monohydrate
MAGNESIUM STEARATE
POLACRILIN POTASSIUM
MICROCRYSTALLINE CELLULOSE
Product Characteristics
Color WHITE Score 2 pieces
Shape PENTAGON (5 sided) (SHIELD SHAPE) Size 6mm
Flavor Imprint Code A;BPI;64
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0187-0064-01 100 TABLET in 1 BOTTLE None
2 NDC:0187-0064-50 500 TABLET in 1 BOTTLE None
3 NDC:0187-0064-10 1000 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017794 05/01/2013
ATIVAN lorazepam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0187-0065
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
lorazepam (lorazepam) lorazepam 2 mg
Inactive Ingredients
Ingredient Name Strength
lactose monohydrate
MAGNESIUM STEARATE
POLACRILIN POTASSIUM
MICROCRYSTALLINE CELLULOSE
Product Characteristics
Color WHITE Score 2 pieces
Shape PENTAGON (5 sided) (SHIELD SHAPE) Size 7mm
Flavor Imprint Code A;2;BPI;65
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0187-0065-01 100 TABLET in 1 BOTTLE None
2 NDC:0187-0065-50 500 TABLET in 1 BOTTLE None
3 NDC:0187-0065-10 1000 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017794 05/01/2013
Labeler — Bausch Health US LLC (831922468)
Establishment
Name Address ID/FEI Operations
Bausch Health Companies Inc. 253292734 MANUFACTURE (0187-0063), MANUFACTURE (0187-0064), MANUFACTURE (0187-0065), PACK (0187-0063), PACK (0187-0064), PACK (0187-0065)

Revised: 10/2020 Bausch Health US LLC

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2021. All Rights Reserved.